Jan 14 (Reuters) - Cyclopharm Ltd (CYC) :
- USFDA APPROVAL PROGRESS FOR TECHNEGAS AND BUSINESS UPDATE-CYC.AX
- TOTAL UNAUDITED REVENUE FOR 2020 WAS IN LINE WITH PRIOR YEAR AT A$14M
- US FDA APPROVAL TARGETED FOR Q2 ON TRACK WITH PRE‐APPROVAL AUDIT SCHEDULED FOR WEEK COMMENCING 29 MARCH 2021
- FAVOURABLE PROGRESS BEING MADE WITH REGARD TO LITIGATION PROCESS AGAINST FORMER EMPLOYEES
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
77.0¢ |
Change
-0.070(8.33%) |
Mkt cap ! $85.57M | |||
| Open | High | Low | Value | Volume |
| 84.0¢ | 84.0¢ | 75.5¢ | $160.3K | 200.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2999 | 77.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 79.5¢ | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 11/09/2025 (20 minute delay) ? |
| CYC (ASX) Chart |